Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials.

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Drusano, G L, Yuen, G J, Morse, G, Cooley, T P, Seidlin, M, Lambert, J S, Liebman, H A, Valentine, F T, Dolin, R
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 1992
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190332/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416828/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.6.1280
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars